CUSIP: 717224109
What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q1 | 0 | $0 | -$15,552 | 0 | |
| 2022 Q4 | 557,722 | $15,552 | -$3,799,000 | $0.03 | 4 |
| 2022 Q3 | 22,129,138 | $3,891,065 | -$785,163 | $0.18 | 26 |
| 2022 Q2 | 23,396,448 | $14,037,047 | -$8,719,537 | $0.60 | 42 |
| 2022 Q1 | 29,394,391 | $38,801,393 | +$687,037 | $1.32 | 53 |
| 2021 Q4 | 28,138,378 | $73,437,206 | -$9,079,026 | $2.61 | 47 |
| 2021 Q3 | 30,813,152 | $95,826,492 | +$996,233 | $3.11 | 58 |
| 2021 Q2 | 30,417,085 | $113,148,520 | -$5,321,247 | $3.72 | 51 |
| 2021 Q1 | 31,841,834 | $110,151,220 | +$55,091,388 | $3.46 | 59 |
| 2020 Q4 | 15,781,999 | $53,028,883 | -$4,537,699 | $3.36 | 56 |
| 2020 Q3 | 17,128,828 | $60,120,843 | -$5,208,494 | $3.51 | 49 |
| 2020 Q2 | 18,335,192 | $84,333,772 | +$85,004 | $4.60 | 59 |
| 2020 Q1 | 18,469,511 | $61,110,981 | -$3,921,637 | $3.31 | 48 |
| 2019 Q4 | 19,395,520 | $118,487,548 | -$2,578,623 | $6.11 | 50 |
| 2019 Q3 | 18,531,408 | $77,265,227 | -$12,431,516 | $4.17 | 56 |
| 2019 Q2 | 18,573,918 | $243,679,459 | +$153,530,591 | $13.12 | 50 |
| 2019 Q1 | 6,922,693 | $65,835,000 | +$2,784,920 | $9.51 | 19 |
| 2018 Q4 | 6,874,034 | $21,240,000 | +$21,240,000 | $3.09 | 14 |